These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17194966)

  • 1. Anti-mullerian hormone: clinical relevance in assisted reproductive therapy.
    Fréour T; Mirallié S; Colombel A; Bach-Ngohou K; Masson D; Barrière P
    Ann Endocrinol (Paris); 2006 Dec; 67(6):567-74. PubMed ID: 17194966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
    Peñarrubia J; Fábregues F; Manau D; Creus M; Casals G; Casamitjana R; Carmona F; Vanrell JA; Balasch J
    Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
    Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
    Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Müllerian hormone and its role in ovarian function.
    Gruijters MJ; Visser JA; Durlinger AL; Themmen AP
    Mol Cell Endocrinol; 2003 Dec; 211(1-2):85-90. PubMed ID: 14656480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?
    Muttukrishna S; McGarrigle H; Wakim R; Khadum I; Ranieri DM; Serhal P
    BJOG; 2005 Oct; 112(10):1384-90. PubMed ID: 16167941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibins, activins and anti-Müllerian hormone: structure, signalling pathways, roles and predictive value in reproductive medicine].
    Deffieux X; Antoine JM
    Gynecol Obstet Fertil; 2003 Nov; 31(11):900-11. PubMed ID: 14623553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF/ICSI patients?
    Muttukrishna S; Suharjono H; McGarrigle H; Sathanandan M
    BJOG; 2004 Nov; 111(11):1248-53. PubMed ID: 15521870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of serum anti-Müllerian hormone by Beckman Coulter ELISA and DSL ELISA: comparison and relevance in assisted reproduction technology (ART).
    Fréour T; Mirallié S; Bach-Ngohou K; Denis M; Barrière P; Masson D
    Clin Chim Acta; 2007 Jan; 375(1-2):162-4. PubMed ID: 16860302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of serum Anti-Mullerian Hormone levels on the results of assisted reproductive technologies. Single-center retrospective study from 2011 cycles (ICSI and bilateral tubal obstruction excluded)].
    Dosso N; Robin G; Catteau-Jonard S; Pigny P; Leroy-Billiard M; Dewailly D
    J Gynecol Obstet Biol Reprod (Paris); 2015 Jan; 44(1):63-71. PubMed ID: 24951378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
    Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
    Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hormone determination in the management and monitoring of cycles of medically-assisted reproductive technology: value and difficulties of use].
    Taieb J; Benattar C; Poüs C
    Ann Biol Clin (Paris); 2003; 61(5):533-40. PubMed ID: 14671750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of anti-Müllerian hormone in follicle recruitment and maturation].
    Visser J
    J Gynecol Obstet Biol Reprod (Paris); 2006 Sep; 35(5 Pt 2):2S30-2S34. PubMed ID: 17057619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of anti-Müllerian hormone in predicting pregnant outcomes of polycystic ovary syndrome patients undergone assisted reproductive technology].
    Li Y; Tan JQ; Mai ZY; Yang DZ
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jan; 53(1):23-30. PubMed ID: 29374882
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology.
    La Marca A; Giulini S; Tirelli A; Bertucci E; Marsella T; Xella S; Volpe A
    Hum Reprod; 2007 Mar; 22(3):766-71. PubMed ID: 17071823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome.
    Eldar-Geva T; Ben-Chetrit A; Spitz IM; Rabinowitz R; Markowitz E; Mimoni T; Gal M; Zylber-Haran E; Margalioth EJ
    Hum Reprod; 2005 Nov; 20(11):3178-83. PubMed ID: 16113044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of the localisation of endometriosis lesions on ovarian reserve and assisted reproduction techniques outcomes.
    Ashrafi M; Arabipoor A; Hemat M; Salman-Yazdi R
    J Obstet Gynaecol; 2019 Jan; 39(1):91-97. PubMed ID: 30257599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of anti-Müllerian hormone for controlled ovarian stimulation in assisted reproductive technology, fertility assessment and -counseling.
    Pilsgaard F; Grynnerup AG; Løssl K; Bungum L; Pinborg A
    Acta Obstet Gynecol Scand; 2018 Sep; 97(9):1105-1113. PubMed ID: 29476703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of age and antimullerian hormone in assisted reproductive technology program outcome.
    Himabindu Y; Gopinathan KK; Pandey AK; Sriharibabu M
    Indian J Physiol Pharmacol; 2013; 57(1):9-15. PubMed ID: 24020093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-mullerian hormone and its role in the regulation of ovarian function. Review of the literature].
    Tsepelidis S; Demeestere I; Delbaere A; Gervy C; Englert Y
    Rev Med Brux; 2007; 28(3):165-71. PubMed ID: 17708472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early follicular antimüllerian hormone as an indicator of ovarian reserve.
    Fiçicioglu C; Kutlu T; Baglam E; Bakacak Z
    Fertil Steril; 2006 Mar; 85(3):592-6. PubMed ID: 16500324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.